Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Vellanki and Chow take on CBO and CFO roles
December 2, 2013
By: Tim Wright
Editor-in-Chief, Contract Pharma
Avanish Vellanki has been appointed chief business officer and Gregory K. Chow has been named chief financial officer at Lorus Therapeutics, Inc. Mr. Vellanki will manage global business development, licensing and corporate strategy. Mr. Chow will have global responsibility for corporate finance and accounting functions. Both Mr. Vellanki and Mr. Chow will report to William G. Rice, Ph.D., chairman and chief executive officer of Lorus. Mr. Vellanki mostly recently served as senior vice president in Investment Banking at Wedbush Securities in San Francisco, covering the biotechnology sector. Previously, he was a senior director of corporate development of Proteolix, Inc. (acquired by Onyx Pharmaceuticals), focused on the development of oncology therapeutics. He also served as vice president in the Global Healthcare Investment Banking team at Citigroup, and was an equity research analyst at Bear Stearns, covering the small/mid-cap biotechnology sector. Mr. Chow previously served as managing director, and led the Private Placements team in the Life Sciences Investment Banking Group at Wedbush Securities. Prior to Wedbush, he was a director in the Private Placements / Equity Capital Markets Group at RBC Capital Markets, where he led the life science private capital activities. Prior to RBC, he directed the Private Capital Group at Wells Fargo Securities, and was a senior auditor at BDO Seidman, LLP. Mr. Chow is a Certified Public Accountant in the State of California. “Mr. Vellanki and Mr. Chow represent critical additions to the team at this pivotal point in the Company’s transition in leadership and focus,” said Dr. Rice. “Avanish brings considerable experience from the life science and banking industries that will boost our abilities to build and advance our oncology pipeline and identify new markets for Lorus’ platform. Greg brings impressive corporate finance and capital raising experience for life science companies, as well as deep industry relationships essential to establishing a foundation for Lorus’ value and future growth.”
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !